PRESCRIPTION PHARMACEUTICAL PREPARATIONS BIOLOGICS

Brand Owner Address Description
PHARMAESSENTIA PharmaEssentiA Corporation 13F, NO. 3, PARK ST., NANGANG DISTRICT TAIPEI 11503 Taiwan Prescription pharmaceutical preparations of biologics containing recombinant protein contained in pre-filled syringes for subcutaneous injection for the treatment of cancers under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription pharmaceutical preparations of biologics containing recombinant protein contained in pre-filled syringes for subcutaneous injection for the treatment of infectious hepatitis under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription pharmaceutical preparations of biologics containing recombinant protein contained in pre-filled syringes for subcutaneous injection for the treatment of cancers and infectious hepatitis under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription pharmaceutical preparations of biologics containing recombinant cells contained in pre-filled syringes for subcutaneous injection for the treatment of cancers under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription pharmaceutical preparations of biologics containing recombinant cells contained in pre-filled syringes for subcutaneous injection for the treatment of infectious hepatitis under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription pharmaceutical preparations of biologics containing recombinant cells contained in pre-filled syringes for subcutaneous injection for the treatment of cancers and infectious hepatitis under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription pharmaceutical preparations of biologics containing recombinant protein and cells contained in pre-filled syringes for subcutaneous injection for the treatment of cancers under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription pharmaceutical preparations of biologics containing recombinant protein and cells contained in pre-filled syringes for subcutaneous injection for the treatment of infectious hepatitis under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription pharmaceutical preparations of biologics containing recombinant protein and cells contained in pre-filled syringes for subcutaneous injection for the treatment of cancers and infectious hepatitis under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription medical preparations containing ropeginterferon alfa-2b contained in pre-filled syringes for subcutaneous injection for the treatment of cancers under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription medical preparations containing ropeginterferon alfa-2b contained in pre-filled syringes for subcutaneous injection for the treatment of infectious hepatitis under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics; prescription medical preparations containing ropeginterferon alfa-2b contained in pre-filled syringes for subcutaneous injection for the treatment of cancers and infectious hepatitis under the supervision of a clinical physician and obtained from a specialty pharmacy for biologics;PHARMACEUTICAL ESSENTIAL;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.